LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 1.62.
| Share Price | ₹60.7 | Mar 02,2026 |
| Market Cap | ₹216.6 Cr | |
| Sales-TTM | ₹133.8 Cr | TTM-Consolidated Results |
| Price/Sales | 1.62x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹216.6 Cr] as on Mar 02,2026
(/) Sales [ ₹133.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.62x ]
Thus, for LYKA LABS , the investors are currently willing to pay '1.62 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.41x.
- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2021 of 0.86x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LYKA LABS | 133.8 | 1.62 | 216.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.40 | 420,531.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.48 | 169,989.0 |
| CIPLA LTD | 28,351.1 | 3.85 | 109,200.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.61 | 147,936.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.12 | 108,057.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.66 | 92,672.7 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.50 | 91,250.3 |
| LUPIN LTD | 26,150.5 | 4.04 | 105,650.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.12 | 70,355.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.35 | 57,006.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.62x |
| Max industry PS | 16.48x |
| Median industry PS | 4.04x |
| Average industry PS | 6.25x |
You may also like the below Video Courses